Mycenax Biotech Inc.
http://www.mycenax.com.tw
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Mycenax Biotech Inc.
Gedeon Richter Teases Denosumab Partnering Opportunity In Japan
While investigating the potential of the Japanese market for its denosumab, Gedeon Richter is preparing for several regulatory filings, including its tocilizumab biosimilar.
Roche’s Actemra Scores New Indication In Rare Autoimmune Disease
The blockbuster drug is expected to see overall sales declines in the next few years, and biosimilar competition could come as soon as 2023.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Contract Manufacturing Organization
-
Pharmaceuticals
- Generic Drugs
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice